Chinese Journal of Contemporary Neurology and Neurosurgery (Dec 2011)

Influence of polyamine analogue DENSPM on cell growth of human SNB19 glioblastoma cells

  • Ye TIAN,
  • Bin WANG,
  • Shizhao WANG,
  • Zhengjun WEI,
  • Lin SUN,
  • Rongcai JIANG,
  • Jianning ZHANG

Journal volume & issue
Vol. 11, no. 6
pp. 614 – 619

Abstract

Read online

Objective To investigate the influence of polyamine analogue DENSPM (N1, N11-diethylnorspermine) on cell growth of human SNB19 glioblastoma cells. Methods DENSPM was added into the culture medium of SNB19 cells. MTS assay was used to assess cell survival rate. The change of the cell cycle and the value of intracellular H2O2 were evaluated by flow cytometry. The level of polyamine was measured by HPLC. The expression of ornithine decarboxylase (ODC), spermidine/spermine N(1)-acetyltransferase (SSAT), polyamine oxidase (PAO) mRNA was identified by quantitative RT-PCR. Results Cell survival rate of SNB19 cells decreased markedly after DENSPM treatment (F = 81.915, P = 0.001). DENSPM treatment led to the appearance of typical sub-G1 peak in flow cytometry assay. The levels of putrescine, spermidine and spermine reduced (P 0.05). Conclusion The polyamine analogue DENSPM inhibits cell growth and induces apoptosis of SNB19 glioblastoma cells. Reduction of polyamine in SNB19 cells is the possible mechanism of apoptosis. DENSPM may be a potential medication for glioblastoma. DOI:10.3969/j.issn.1672-6731.2011.06.006

Keywords